3 Stocks I Saw on T...
Health Care: Drugs
Akorn Inc. (AKRX: NASDAQ)
$13.75 0.45 | 3.38%
06/04/12 - 02:55 PM ET
Company Balance Sheet
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 83.96M | 41.62M | 1.62M | 1.06M |
| Receivables | 25.31M | 11.27M | 10.06M | 7.75M |
| Inventories | 35.46M | 18.92M | 13.17M | 30.16M |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 155.95M | 73.61M | 26.07M | 40.75M |
| Property, Plant & Equipment, Gross | 87.45M | 72.39M | 67.64M | 66.93M |
| Accumulated Depreciation & Depletion | 43.06M | 39.66M | 36.17M | 32.71M |
| Property, Plant & Equipment, Net | 44.39M | 32.73M | 31.47M | 34.22M |
| Intangibles | 80.84M | 3.12M | 4.62M | 6.02M |
| Other Non-Current Assets | 14.11M | 1.65M | 6.60M | 1.34M |
| Total Non-Current Assets | 151.20M | 37.50M | 42.69M | 41.58M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 307.14M | 111.12M | 68.76M | 82.33M |
| Accounts Payable | 17.87M | 4.89M | 3.29M | 8.80M |
| Short Term Debt | 0.00 | 0.00 | 3.00M | 5.33M |
| Other Current Liabilities | 0.00 | 10.18M | 10.56M | 0.00 |
| Total Current Liabilities | 28.29M | 21.94M | 21.67M | 18.10M |
| Long Term Debt | 114.65M | 0.00 | 5.85M | 0.00 |
| Deferred Income Taxes | 3.74M | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 2.26M | 1.30M | 1.30M | 1.30M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 120.65M | 2.42M | 8.46M | 2.78M |
| Total Liabilities | 148.94M | 24.36M | 30.12M | 20.89M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 158.21M | 86.75M | 38.64M | 61.44M |
| Common Par | 0.00 | 0.00 | 0.00 | 0.00 |
| Additional Paid In Capital | 212.64M | 182.47M | 174.03M | 170.62M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -72.37M | -115.39M | -137.21M | -111.90M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 17.95M | 19.67M | 1.82M | 2.73M |
| Total Capitalization | 272.86M | 86.75M | 44.49M | 61.44M |
| Total Equity | 158.21M | 86.75M | 38.64M | 61.44M |
| Total Liabilities & Stock Equity | 307.14M | 111.12M | 68.76M | 82.33M |
| Total Common Shares Outstanding | 94.94M | 93.98M | 90.39M | 90.12M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 94.55M | 92.80M | 90.25M | 89.21M |
| Diluted Weighted Shares Outstanding | 103.91M | 99.25M | 90.25M | 89.21M |
| Number of Employees | 553 | 410 | 329 | 351 |
| Number of Part-Time Employees | 11 | 0 | 0 | 0 |
Portfolios with AKRX
- Portfolio NameUser Type
- UserGFNN Stockdiagnostics 16
- UserGFNN Stockdiagnostics 11
- Userpharmacy
- UserGFNN Stockdiagnostics 4
- UserDIGGITY PORTFOLIO
- UserGFNN Stockdiagnostics
- ContributorStocks At New 52-Week Highs...
- UserDivatrades
- Contributor5 Stocks Under-$10 Setting ...
- UserMister 600
Latest AKRX Headlines from TheStreet
- Akorn Stock Hits New 52-Week High (AKRX) 05.30.12 | 02:05 pm
- 3 Stocks Hit 52-Week Highs 05.15.12 | 02:05 pm
- Akorn Stock Hits New 52-Week High (AKRX) 05.15.12 | 09:05 am
- Akorn Reaches New 52-Week High (AKRX) 02.29.12 | 10:02 am
- Akorn Rises On Unusually High Volume (AKRX) 02.13.12 | 04:02 pm
- 3 Stocks Hitting 52-Week Highs: Akorn, Sunoco Logistics, Cincinnati Financial 02.10.12 | 02:02 pm
- Akorn Reaches New 52-Week High (AKRX) 02.10.12 | 12:02 pm
- Akorn Reaches New 52-Week High (AKRX) 02.01.12 | 09:02 am
- Akorn Reaches New 52-Week High (AKRX) 12.19.11 | 10:12 am
- 6 Stocks at New 52-Week Highs 12.13.11 | 01:12 pm
Press Releases for AKRX
- Akorn Reports Record First Quarter 2012 Financial Results - Business Wire 05.08.12 | 06:05 am
- Akorn Announces The Approval And Launch Of Generic Vancocin® - Business Wire 04.10.12 | 06:04 am
- Brinson Patrick Securities Initiates Research Coverage Of Akorn, Inc. - PR Newswire 03.22.12 | 03:03 pm
- Akorn Reports 2011 Fourth Quarter And Year-End Financial Results - Business Wire 03.06.12 | 07:03 am
- Akorn Announces The Appointment Of Dr. Adrienne Graves, Ph.D. To Its Board Of Directors - Business Wire 03.05.12 | 08:03 pm
- Akorn Completes The Acquisition Of Certain Assets Of Kilitch Drugs In India - Business Wire 02.28.12 | 07:02 pm
- Akorn Provides Financial Guidance For 2012 - Business Wire 01.17.12 | 07:01 am
- Akorn Acquires Three Hospital-Based Branded Injectables From Lundbeck - Business Wire 12.22.11 | 01:12 pm
- Akorn Reports Record Third Quarter 2011 Financial Results - Business Wire 11.01.11 | 07:11 am
- Akorn Enters Into An Agreement To Acquire Certain Assets Of Kilitch Drugs In India - Business Wire 10.06.11 | 12:10 am
Partner Headlines for AKRX
- Zacks Releases Four Powerful ''Buy'' Stocks: BE Aerospace, Yum! Brands, Akorn and H.B. Fuller - Press Releases - Zacks 02.08.12 | 09:02 am
- Akorn, Inc. - Momentum - Zacks 02.08.12 | 01:02 am
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 01.20.12 | 09:01 am
- End-of-Day Market Summary for December 23, 2011 - Benzinga 12.23.11 | 04:12 pm
- Hearing Akorn Recent Weakness Attributed to FDA Inspection Letter - Benzinga 12.23.11 | 11:12 am
- Akorn Acquires Three Hospital-Based Branded Injectables from Lundbeck; Expected To Add Approximately $30-$35M in 2012 - Benzinga 12.22.11 | 01:12 pm
- Piper Jaffray Maintains Overweight, $12 Target on Akorn - Benzinga 12.15.11 | 09:12 am
- Akorn, Inc - Aggressive Growth - Zacks 11.11.11 | 01:11 am
- Zacks #1 Rank Additions for Thursday - Tale of the Tape - Zacks 11.03.11 | 09:11 am
- These NASDAQ Rockets Should Be In Your Portfolio - Seeking Alpha 10.19.11 | 09:10 am
